Physical Activity for Multiple Sclerosis

LH
Overseen ByLexi Huynh, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Illinois at Chicago
Must be taking: Disease-modifying therapy
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a 16-week program designed to promote physical activity in individuals recently diagnosed with multiple sclerosis (MS). Participants receive remote guidance to increase activity levels, with regular coaching sessions and tools like a Fitbit to track progress. The goal is to determine if this Lifestyle Physical Activity Intervention improves physical activity, reduces fatigue, depression, and anxiety, and enhances overall quality of life. It targets those diagnosed with MS within the last two years, who haven't experienced a relapse in the past month, and who can walk without assistance. As an unphased trial, this study offers a unique opportunity to contribute to research that could enhance the quality of life for those with MS.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, it requires participants to be on a disease-modifying therapy, so you may need to continue that specific treatment.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, it requires participants to be on a disease-modifying therapy, so you may need to continue that specific treatment.

What prior data suggests that this lifestyle physical activity intervention is safe for people with MS?

Research has shown that the Lifestyle Physical Activity Program for people newly diagnosed with multiple sclerosis (MS) is safe. In past studies, this type of program proved practical and well-received. Participants generally found it safe and acceptable.

The program lasts 16 weeks and is conducted remotely. It includes resources like electronic newsletters and regular one-on-one coaching sessions through Zoom. Participants also use a Fitbit to track their daily activity. These tools aim to increase physical activity, which has been linked to better function and quality of life for people with MS.

Overall, this approach has shown promise without major safety concerns. Participants in similar past studies did not report any serious side effects.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores a fresh approach to managing multiple sclerosis (MS) through lifestyle physical activity, rather than relying solely on medication. Unlike traditional MS treatments that often focus on managing symptoms with drugs like interferons or glatiramer acetate, this intervention emphasizes a remote physical activity program. Key features include personalized coaching and real-time activity tracking through a Fitbit, which may empower participants to integrate more movement into their daily lives. This approach could offer a holistic benefit, potentially improving not just physical health, but also mental well-being and overall quality of life for people with MS.

What evidence suggests that this lifestyle physical activity intervention is effective for multiple sclerosis?

Research shows that physical activity programs can benefit people with multiple sclerosis (MS). Studies have found that these programs increase both self-reported and measured physical activity levels. They also reduce fatigue, depression, and anxiety. Many participants report feeling better overall and experiencing a higher quality of life. In this trial, participants in the physical activity condition will receive a remote-delivered physical activity program for 16 weeks, including access to electronic newsletters and regular one-on-one coaching chats over Zoom. These programs can be easily shared with many people, often through online or remote methods.46789

Are You a Good Fit for This Trial?

This trial is for adults over 18 who were diagnosed with Multiple Sclerosis in the last 2 years, can walk without help, have internet access, and are currently not very active. They should be relapse-free for a month, able to read English, and on disease-modifying therapy.

Inclusion Criteria

Internet and e-mail access, and willingness to complete the testing and questionnaires
I was diagnosed with MS by a neurologist in the last 2 years.
I can walk without needing help from a device like a cane.
See 5 more

Exclusion Criteria

Pregnant
Have elevated risk for undertaking strenuous or maximal exercise based on two or more affirmatives on the Physical Activity Readiness Questionnaire (PAR-Q)

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Assessment

Participants complete initial assessments of physical activity, MS symptoms, and physical and cognitive function

1 week
1 visit (virtual)

Treatment

Participants receive a 16-week remotely delivered physical activity intervention with coaching and Fitbit tracking

16 weeks
Weekly virtual coaching sessions

Follow-up Assessment

Participants complete follow-up assessments of physical activity, MS symptoms, and physical and cognitive function

1 week
1 visit (virtual)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Lifestyle Physical Activity Intervention
Trial Overview The study tests if a 16-week program of lifestyle physical activity delivered remotely can improve physical activity levels and quality of life (QoL) compared to those who wait before starting the program.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Waitlist conditionExperimental Treatment1 Intervention
Group II: Physical activity conditionExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Illinois at Chicago

Lead Sponsor

Trials
653
Recruited
1,574,000+

Published Research Related to This Trial

A systematic review of 8 randomized clinical trials involving 919 individuals with multiple sclerosis found no significant differences in step count or moderate to vigorous physical activity levels between those who participated in physical activity interventions and those who did not.
Despite the interventions, the results indicated that physical activity did not lead to measurable improvements in physical activity intensity or step count, suggesting a need for more studies with objective measures to assess the effectiveness of exercise in individuals with MS.
The effect of exercise and physical activity-interventions on step count and intensity level in individuals with multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials.Arntzen, EC., Bidhendi-Yarandi, R., Sivertsen, M., et al.[2023]
Individuals with mild multiple sclerosis (MS) were found to be moderately less physically active than matched controls, with significant differences in various measures of physical activity, including accelerometer counts and self-reported questionnaires.
Despite the observed reduction in physical activity, the study suggests that behavioral interventions could effectively increase activity levels in people with MS, potentially leading to improved health outcomes.
Physical activity and multiple sclerosis: new insights regarding inactivity.Sandroff, BM., Dlugonski, D., Weikert, M., et al.[2022]
Supervised exercise training is highly beneficial for individuals with multiple sclerosis (MS), yet 80% of them do not engage in enough moderate-to-vigorous physical activity (MVPA).
The paper advocates for a shift towards promoting lifestyle physical activity through behavioral interventions, which could complement structured exercise training and improve overall health outcomes for people with MS.
Lifestyle physical activity in persons with multiple sclerosis: the new kid on the MS block.Motl, RW.[2022]

Citations

1.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/38242351/
Internet-delivered lifestyle physical activity intervention for ...We propose a randomized controlled trial(RCT) of a Social Cognitive Theory-based(SCT), Internet-delivered behavioral intervention targeting lifestyle physical ...
2.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/29959105/
Phase-III, randomized controlled trial of the behavioral ...The proposed research will provide evidence for the effectiveness of a novel, widely scalable approach for increasing lifestyle physical activity.
Randomized controlled trial of the behavioral intervention ...There were positive intervention effects on self-reported and device-measured LPA as well as PROs measuring fatigue, depression and anxiety symptoms, walking ...
Primary Results of a Phase-III, Randomized Controlled Trial of ...Background: We undertook a phase-III, randomized controlled trial (RCT) that examined the effectiveness of a behavioral intervention based on social cognitive ...
A web-based life-style, exercise and activity intervention for ...The Lifestyle, Exercise and Activity Package (LEAP-MS) intervention, is a co-designed web-based physical activity intervention for people with progressive ...
Internet-Delivered Lifestyle Physical Activity Intervention for ...We propose a randomized controlled trial(RCT) of a Social Cognitive Theory-based(SCT), Internet-delivered behavioral intervention targeting lifestyle physical ...
Lifestyle Physical Activity Intervention for Persons Newly ...The overall objective of the current study is to determine the efficacy of a 16-week remotely delivered lifestyle behavioral intervention compared with a ...
8.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/38262331/
Feasibility of a theory-based physical activity intervention ...The results indicate that this intervention was feasible, safe, acceptable, and promising for promoting lifestyle PA in persons newly diagnosed with MS.
Physical Activity in Multiple Sclerosis: Real-World Data ...Physical activity in people with multiple sclerosis (MS) has been associated with improved function, 1 participation, 2 and quality of life, 3 ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security